Celcuity (CELC) Long-Term Debt Issuances (2024 - 2025)

Celcuity (CELC) posted Long-Term Debt Issuances of -$7000.0 for Q4 2025, up 12.5% on a QoQ basis from -$8000.0 in Q3 2024.

Celcuity (CELC) Long-Term Debt Issuances (2024 - 2025) Analysis & Trends

Celcuity's Long-Term Debt Issuances history runs 2 years deep, the most recent figure standing at -$7000.0 for Q4 2025.

Quarterly Long-Term Debt Issuances changed N/A year-over-year to -$7000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$15000.0 (down 87.5% YoY) and the FY2025 annual result came in at $27.7 million, down 53.15% from the prior year.
Long-Term Debt Issuances was -$7000.0 for Q4 2025 at Celcuity, up from -$8000.0 in the prior quarter.
Across five years, Long-Term Debt Issuances topped out at -$7000.0 in Q4 2025 and bottomed at -$8000.0 in Q3 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Issuances (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Celcuity	4.13 Bn	4.13 Bn	-	-7,000.00

Download Data